Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Betamethasone dipropionate
Drug ID BADD_D00261
Description Betamethasone is a long-acting corticosteroid with immunosuppressive and antiinflammatory properties.[A192444] It can be used topically to manage inflammatory skin conditions such as eczema, and parenterally to manage several disease states including autoimmune disorders.[A192444] Betamethasone has potent glucocorticoid activity and negligible mineralocorticoid activity.[A192444]
Indications and Usage Systemic use: for the treatment of edocrine disorders, rheumatic disorders, collagen diseases, dermatological diseases, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous states, gastrointestinal diseases, tuberculous meningitis and trichinosis.
Marketing Status Prescription; Discontinued
ATC Code A07EA04; C05AA05; D07AC01; D07XC01; H02AB01; R01AD06; R03BA04; S01BA06; S01CB04; S02BA07; S03BA03
DrugBank ID DB00443
KEGG ID D01637
MeSH ID C011175
PubChem ID 21800
TTD Drug ID Not Available
NDC Product Code 50090-1839; 68788-0382; 0472-0380; 0168-0265; 70771-1550; 63187-286; 50090-4136; 50090-4679; 63629-8613; 68788-7241; 51407-273; 0168-0055; 65089-0009; 50090-5260; 63739-996; 51672-1317; 68040-714; 0713-0728; 22552-0028; 46439-8710; 0168-0056; 0168-0057; 52565-019; 68071-1657; 0168-0268; 50090-1192; 50090-4038; 63629-8614; 0713-0807; 16714-996; 78206-124; 50090-0236; 50090-4680; 68788-9804; 69482-800; 68788-7670; 68071-4556; 72578-093; 67857-808; 51672-1309; 51672-1274; 0713-0659; 50090-3276; 53002-8280; 0472-0382; 52565-023; 50090-5232; 66993-897; 68462-290; 50090-2091; 0472-0381; 51672-1340; 70710-1233; 61748-480; 68071-4814; 61748-475; 68180-947; 68788-9219; 71205-275; 0713-0759; 38779-0017; 52128-160; 49452-1075; 51927-0171; 51672-1310; 51552-0022; 70771-1380; 51672-1390; 45802-376; 45802-021
Synonyms betamethasone-17,21-dipropionate | betamethasone dipropionate | Diprosone | Diprolene | Beloderm | betamethasone propionate | Maxivate | augmented betamethasone dipropionate
Chemical Information
Molecular Formula C28H37FO7
CAS Registry Number 5593-20-4
SMILES CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Atrophy08.03.04.001--Not Available
Blister23.03.01.001; 12.01.06.002--Not Available
Burning sensation17.02.06.001; 08.01.09.029--Not Available
Cushing's syndrome24.08.04.001; 19.07.03.002; 14.11.01.007; 05.01.01.001--Not Available
Dermatitis23.03.04.002--Not Available
Dermatitis acneiform23.02.01.004--
Dermatitis contact12.03.01.040; 10.01.01.003; 23.03.04.004--Not Available
Dry skin23.03.03.001--
Erythema23.03.06.001--Not Available
Folliculitis23.09.04.007; 11.01.12.018--
Glycosuria20.02.01.005--
Hyperaesthesia17.02.06.004--Not Available
Hyperglycaemia05.06.02.002; 14.06.02.002--
Hypertension24.08.02.001--
Hypertrichosis23.02.04.002--
Infection11.01.08.002--Not Available
Leukoderma23.05.02.001--Not Available
Miliaria23.02.03.014--Not Available
Pain08.01.08.004--
Papule23.03.03.038--Not Available
Paraesthesia17.02.06.005--
Pruritus23.03.12.001--
Rash erythematous23.03.06.003--Not Available
Rash follicular23.03.10.001--Not Available
Skin atrophy23.01.05.001--
Skin depigmentation23.05.02.002--Not Available
Skin disorder23.03.03.007--Not Available
Skin hypopigmentation23.05.02.003--
Skin irritation23.03.04.009--Not Available
Skin striae23.01.05.002--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages